Skip to content
zameds

Lamivudine (Aspen Lamivudine, Ap Lamivudine)

Lamivudine

Pharmacare limited û woodmead

S4

Registration

Applicant
Pharmacare limited û woodmead
Registrations
3
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aspen lamivudine 300 MG

EACH TABLET CONTAINS LAMIVUDINE 300,0 mg

300 mg43083243/20.2.8/0832RegisteredS4None
Ap lamivudine 150 MG

EACH TABLET CONTAINS LAMIVUDINE 150,0 mg

150 mg43110243/20.2.8/1102RegisteredS4None
Aspen lamivudine syrup

EACH 1,0 ml SYRUP CONTAINS LAMIVUDINE 10,0 mg

SyrupA380357A38/20.2.8/0357RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Lamivudine

  • S4: Lamivudine

    Consolidated Schedules 06 July 2026, line 6850

Pharmacological class: Antiviral agents. (class 20.2.8)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C8H11N3O3S229.26 g/mol

4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one

Drag to rotate. Structure from PubChem CID 60825.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles